Logistics firms tackle time-critical delivery of radiopharmaceuticals for cancer care

Radiopharmaceuticals are emerging as a key tool in oncology, offering cell‑level targeting that spares healthy tissue while delivering radiation directly to tumors.

Because the radioactive isotopes begin to decay the moment they are produced, the therapeutic value of each dose diminishes with every passing hour, turning distribution into a high‑stakes race against physics.

Air transport now accounts for roughly 61% of all radiopharmaceutical shipments, underscoring the need for ultra‑fast, temperature‑controlled logistics to preserve efficacy.

Specialized providers such as Marken are developing end‑to‑end logistics frameworks designed to move these volatile products on a precise schedule, ensuring they reach patients in optimal condition.